Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Abeona Therapeutics
4143
Abeona Therapeutics
Health Care
Technology
Biotechnology
Medical
Therapeutics
Abeona is developing therapies for children with rare lysosomal diseases for the deadly childhood diseases Sanfilippo (SF) Syndrome Type A and TypeB.
Suggest edits
Type
B2c
Raised
$104.9M
Follow us
Companies in the same industry
Genomics plc
Quentis Therapeutics
BrainStorm Cell Therapeutics
Biscayne NeuroTherapeutics
Ovid Therapeutics
Volastra Therapeutics
BioTheryX
Complexa
Motus Therapeutics
Trobix Bio
Alexa global traffic share
Overview
Funding
4
Add info
Latest funding
Show all
$92,000,000
Post-IPO equity - 2017
$8,500,000
Venture capital - 2015
George Soros
Team Size
1–10
Employees
I work here
Location
United States
Headquarters
Explore United States
No recent coverage
Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Abeona Therapeutics makes some noise.
